Innovation in cancer therapy

21st September 2016

Our second event of Autumn 2016 will be Innovation in cancer therapy, sponsored by AbbVie.

It will centre on the process of valuing new medicines within the NHS and the changes currently taking place in the oncology space including access to medicines and the evolving reimbursement structure.

  • Dr Jonathan Fielden, Director of Specialised Commissioning and Deputy National Director, NHS England
  • Dr Anil Singhal, Vice President of AbbVie and Head of AbbVie Biotherapeutics
  • Dr Liz O’Riordan, Consultant Oncoplastic Breast Surgeon and Commentator